NCT05197517View on ClinicalTrials.gov

Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

October 1, 2020

Study Completion Date

October 1, 2020

Conditions
Bioequivalence
Interventions
DRUG

Rosuvastatin 10 mg

Film Coated Tablets products containing 10 mg Rosuvastatin

Trial Locations (1)

Unknown

Future Research Center (FRC), Cairo

All Listed Sponsors
collaborator

Future University in Egypt

OTHER

lead

Rania Mahmoud Mohamed

OTHER

NCT05197517 - Bioequivalence Study of Rosuvastatin in Healthy Volunteers Under Fasting Condition | Biotech Hunter | Biotech Hunter